LIMN (STOCKS)
Liminatus Pharma, Inc. Class A Common Stock
$0.182500
-0.005000 (-2.67%)
Prev close: $0.187500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Chris Kim
- Asset Type
- stocks
- Website
- —
Fundamentals
- Market Cap
- $8.21M
- Employees
- 1
- P/E (TTM)
- -0.49
- P/B (TTM)
- -0.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$7.24M |
| Operating Expenses | $2.97M |
| Operating Income/Loss | -$2.97M |
| Income/Loss From Continuing Operations After Tax | -$10.21M |
| Income/Loss From Continuing Operations Before Tax | -$10.21M |
| Net Income/Loss | -$10.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.43 |
| Diluted Earnings Per Share | -$0.43 |
| Basic Average Shares | 23,753,561 |
| Diluted Average Shares | 23,753,561 |
| Assets | $512.80K |
| Current Assets | $500.57K |
| Noncurrent Assets | $12.22K |
| Fixed Assets | $12.22K |
| Liabilities | $10.33M |
| Current Liabilities | $10.30M |
| Noncurrent Liabilities | $29.24K |
| Equity | -$9.81M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$9.81M |
| Liabilities And Equity | $512.80K |
| Net Cash Flow From Operating Activities | -$9.96M |
| Net Cash Flow From Operating Activities, Continuing | -$9.96M |
| Net Cash Flow From Investing Activities | -$788.11K |
| Net Cash Flow From Investing Activities, Continuing | -$788.11K |
| Net Cash Flow From Financing Activities | $11.03M |
| Net Cash Flow From Financing Activities, Continuing | $11.03M |
| Net Cash Flow | $281.34K |
| Net Cash Flow, Continuing | $281.34K |
| Comprehensive Income/Loss | -$10.21M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.21M |
| Other Comprehensive Income/Loss | $0.00 |